CAS 31690-09-2

L-Metilfolato

Descripción:

L-Metilfolato, con el número CAS 31690-09-2, es la forma biológicamente activa del folato, una vitamina B (B9) que desempeña un papel crucial en varios procesos fisiológicos. Es esencial para la síntesis, reparación y metilación del ADN, así como para la producción de glóbulos rojos. L-Metilfolato es particularmente importante en el metabolismo de la homocisteína, un aminoácido relacionado con la salud cardiovascular. Este compuesto es soluble en agua y generalmente existe como un polvo cristalino blanco a amarillo pálido. Es estable en condiciones normales, pero puede ser sensible a la luz y al calor. L-Metilfolato se utiliza a menudo en suplementos dietéticos y fortificación debido a su mayor biodisponibilidad en comparación con otras formas de folato, como el ácido fólico. Es particularmente beneficioso para individuos con ciertos polimorfismos genéticos que afectan la conversión del ácido fólico a su forma activa. Además, se ha estudiado L-Metilfolato por sus posibles efectos terapéuticos en trastornos del estado de ánimo y otras condiciones de salud, destacando su importancia tanto en la nutrición como en la medicina.

Fórmula: C₂₀H₂₅N₇O₆

InChI: InChI=1S/C20H25N7O6/c1-27-12(9-23-16-15(27)18(31)26-20(21)25-16)8-22-11-4-2-10(3-5-11)17(30)24-13(19(32)33)6-7-14(28)29/h2-5,12-13,22H,6-9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H4,21,23,25,26,31)/t12-,13-/m0/s1

Clave InChI: InChIKey=ZNOVTXRBGFNYRX-STQMWFEESA-N

SMILES: CN1C2=C(NC[C@@H]1CNC3=CC=C(C(N[C@@H](CCC(O)=O)C(O)=O)=O)C=C3)NC(N)=NC2=O

Sinónimos:

• L-Glutamic acid, N-[4-[[(2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-, (S)-
• L-Glutamic acid, N-[4-[[[(6S)-2-amino-3,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-
• N-[4-[[[(6S)-2-Amino-3,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-L-glutamic acid
• L-Glutamic acid, N-[4-[[[(6S)-2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-
• Glutamic acid, N-[p-[[(2-amino-5,6,7,8-tetrahydro-4-hydroxy-5-methyl-6-pteridinyl)methyl]amino]benzoyl]-, L-(-)-

Levomefolic Acid

CAS: 31690-09-2

Fórmula: C₂₀H₂₅N₇O₆

Pureza: >98.0%(HPLC)

Forma y color: White to Light yellow powder to crystal

Peso molecular: 459.46

Ref: 3B-L0335

(S)-N-[4-[[(2-Amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid

CAS: 31690-09-2

Fórmula: C₂₀H₂₅N₇O₆

Pureza: 98%

Forma y color: Solid

Peso molecular: 459.4558

Ref: IN-DA0039B6

Levomefolic Acid

CAS: 31690-09-2

Levomefolic Acid

Pureza: ≥95%

Peso molecular: 459.46g/mol

Ref: 54-BUP14491

Levomefolic Acid

CAS: 31690-09-2

Levomefolic Acid

Pureza: 98%

Peso molecular: 459.46g/mol

Ref: 54-OR1030497

Levomefolic Acid (L-5-Methyltetrahydrofolic Acid)

CAS: 31690-09-2

Fórmula: C₂₀H₂₅N₇O₆

Peso molecular: 459.47

Ref: 4Z-L-382

Levomefolic Acid

CAS: 31690-09-2

Levomefolic Acid (5-MTHF) is a natural, active form of folic acid used at the cellular level for DNA reproduction and the cysteine cycle among other functions.

Fórmula: C₂₀H₂₅N₇O₆

Pureza: 97.27%

Forma y color: Solid

Peso molecular: 459.46

Ref: TM-T7094

Levomefolic Acid

CAS: 31690-09-2

Applications A natural, active form of folic acid used at the cellular level for DNA reproduction, the cysteine cycle and the regulation of homocysteine among other functions. It is a coenzymated form of folic acid. It has been proposed for treatment of cardiovascular disease.
References Willems, F. et al.: Br. J. Pharmacol., 145, 823 (2004); Prinz-Langhebohi, R.: et al., Br. J. Pharmacol., 158, 2014 (2009); Wright, A. et al.: Brit, J. Nutrit., 103, 724 (2010)

Fórmula: C₂₀H₂₅N₇O₆

Forma y color: Neat

Peso molecular: 459.46

Ref: TR-L375730

Levomefolic acid

CAS: 31690-09-2

Levomefolic acid is a derivative of folic acid and belongs to the group of dinucleotide phosphates. It has been shown to have a protective effect against blood clots, and is used in the treatment of pernicious anaemia, megaloblastic anaemia, and leukopenia. Levomefolic acid also inhibits energy metabolism in bacteria. Its mode of action is not fully understood but it has been demonstrated that it inhibits enzyme activities such as methylenetetrahydrofolate reductase (MTHFR) and 5-methyltetrahydrofolate cyclohydrolase. The production of DNA nucleotides has also been shown to be inhibited by the drug. Levomefolic acid has also been shown to have an effect on redox potentials in cancer cell lines. In addition, it has been found that levomefolic acid can be transferred from maternal blood to human serum.

Fórmula: C₂₀H₂₅N₇O₆

Pureza: Min. 95 Area-%

Forma y color: White Powder

Peso molecular: 459.46 g/mol

Ref: 3D-FL24884